Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 1

Research Article

The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care

Table 1

Characteristics and demographics of patients included in the study, according to their referring physicians’ reports and comparing the groups of continuous treatment to early determination.

All patientsContinuous cannabis useEarly determination value

No. of patients21110625
Age:
 ≤30 years
 31–70 years
 ≥71 years
29 (14%)
117 (55%)
65 (31%)
19 (18%)
58 (54%)
29 (28%)
1 (4%)
15 (60%)
9 (36%)
0.12
Gender:
 Male
 Female
126 (60%)
85 (40%)
65 (59%)
45 (41%)
11 (44%)
14 (56%)
0.18
Academic studies108 (51%)61 (56%)15 (60%)0.98
Reasons for cannabis use (physician’s recommendation)
 Previous treatment not satisfactory
 Others
152 (72%)
59 (28%)
94 (87%)
12 (13%)
11 (44%)
14 (56%)
<0.001
Primary tumor:
 Lung
 Breast
 Gastrointestinal
 Hematological
 Other
45 (21%)
20 (9%)
55 (27%)
27 (12%)
54 (31%)
18 (17%)
12 (11%)
36 (34%)
16 (15%)
22 (23%)
7 (28%)
3 (12%)
4 (16%)
2 (8%)
9 (36%)
0.2
CNS involvement20 (9%)5 (5%)6 (24%)0.006
Oncology treatment aim:
 Curative/adjuvant
 Palliative
99 (47%)
112 (53%)
56 (53%)
50 (47%)
13 (52%)
12 (48%)
0.99
Chemotherapy during last 3 months156 (74%)81 (75%)18 (72%)0.80
Radiotherapy during last 3 months51 (24%)23 (21%)7 (28%)0.59
Chemotherapy-induced nausea and vomiting48 (23%)33 (31%)2 (8%)0.002
Fatigue93 (44%)46 (43%)9 (36%)0.65
Anorexia/weight loss104 (49%)59 (55%)6 (24%)0.007
Depression/anxiety72 (34%)40 (37%)7 (28%)0.49
Opioid use110 (52%)60 (56%)12 (48%)0.51
Anti-depressant/anxiety use76 (36%)44 (42%)6 (24%)0.34
Steroid use96 (45%)49 (45%)9 (36%)0.50

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.